<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28518" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Rheumatoid Arthritis and Ankylosing Spondylitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akhondi</surname>
            <given-names>Hossein</given-names>
          </name>
          <aff>University of Nevada</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varacallo</surname>
            <given-names>Matthew</given-names>
          </name>
          <aff>Penn Highlands Healthcare System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hossein Akhondi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Varacallo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28518.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are among the most common rheumatic diseases. These chronic progressive inflammatory diseases lead to a reduction in physical fitness and increase in joint degeneration. Although very closely related, their symptomatology and etiology are different. This activity identifies factors that distinguish rheumatoid arthritis from ankylosing spondylitis and highlights the role of the interprofessional team in caring for patients with these conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain how to differentiate rheumatoid arthritis and ankylosing spondylitis in a patient with small joint pain. Use data available for this differentiation.</p></list-item><list-item><p>Describe the similarities as well as differences between rheumatoid arthritis and ankylosing spondylitis.</p></list-item><list-item><p>Outline management strategies for rheumatoid arthritis and ankylosing spondylitis. Different approaches and different medication available for this purpose. Recognize the use of non-pharmacological modalities for management.</p></list-item><list-item><p>Review interprofessional team strategies to improve care coordination and communication amongst interprofessional team members and improve outcomes for patients with rheumatoid arthritis and ankylosing spondylitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28518&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28518">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28518.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are among the most common rheumatic diseases. These chronic progressive inflammatory diseases lead to a reduction in physical fitness and increase in joint degeneration.<xref ref-type="bibr" rid="article-28518.r1">[1]</xref> Although very&#x000a0;closely related, their symptomatology and etiology are different. In the past, AS was often diagnosed inaccurately as RA, but the two have recently&#x000a0;been recognized as separate, distinct clinical&#x000a0;entities.&#x000a0; The latter has&#x000a0;been attributed to advancing diagnostic and laboratory techniques able to differentiate the&#x000a0;two conditions.<xref ref-type="bibr" rid="article-28518.r2">[2]</xref>&#x000a0;That being said, the diagnostic differentiation still&#x000a0;remains a challenging task for clinicians.</p>
        <p>Both RA and AS can be similarly characterized by the&#x000a0;presenting&#x000a0;symptoms, radiographic characteristics, and serological testing.&#x000a0; However, RA and AS have widely different characteristics with respect&#x000a0;to each one's pathophysiology and underlying genetic parameters.<xref ref-type="bibr" rid="article-28518.r3">[3]</xref><xref ref-type="bibr" rid="article-28518.r4">[4]</xref> This makes the probability of a patient having both conditions rather low. Considering that the two have&#x000a0;some similar clinical manifestation such as changes on radiography or&#x000a0;peripheral/morning stiffness, however,&#x000a0;the diagnosis can be a challenge, and more tests may be required to establish the correct etiology.<xref ref-type="bibr" rid="article-28518.r5">[5]</xref>&#x000a0;Furthermore, authors have reported cases of coexisting AS and RA&#x000a0;since 1976.</p>
      </sec>
      <sec id="article-28518.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Various studies have suggested that rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have overlapping etiologies.<xref ref-type="bibr" rid="article-28518.r6">[6]</xref>&#x000a0;These suggestions are based on the different genetic backgrounds that result in the development of the conditions in a patient. If a patient has human leukocyte antigen (HLA) HLA-DR4 of RA and the predisposing HLA-B27 of AS at the same time and is affected by an environmental agent, then there is a chance&#x000a0;of RA and AS coexistence.<xref ref-type="bibr" rid="article-28518.r7">[7]</xref>&#x000a0;The first case of simultaneous RA and AS was&#x000a0;reported&#x000a0;in 1976. Since that first report, there have been fewer than 60 such cases reported.<xref ref-type="bibr" rid="article-28518.r8">[8]</xref>&#x000a0;This under-reporting can be attributed to the lack of clinical examination, observation, or complete evaluation.&#x000a0;</p>
      </sec>
      <sec id="article-28518.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The occurrence of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) in the general population has a frequency between 0.3% and 1.5%.<xref ref-type="bibr" rid="article-28518.r9">[9]</xref>&#x000a0; AS is more common in males and RA is more common in females. AS associated symptoms show before the age of 30, but&#x000a0;RA happens&#x000a0;later, between 40 and 50 years of age.&#x000a0;&#x000a0;</p>
        <p>Studies estimate that 90% of patients with RA develop cervical spondylitis. However, recently RA cervical spondylitis presents with classic patterns of instability, including atlantoaxial subluxation, subaxial subluxation, and basilar invagination.&#x000a0; The latter occurs in about 20% of RA patients&#x000a0;<xref ref-type="bibr" rid="article-28518.r10">[10]</xref>. &#x000a0;</p>
        <p>Globally, the prevalence varies depending upon the ethnic group and with the prevalence of human leukocyte antigen (HLA)-B27. The prevalence of AS is approximately 5% to 6% among people who are HLA-B27-positive.<xref ref-type="bibr" rid="article-28518.r11">[11]</xref></p>
      </sec>
      <sec id="article-28518.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Epidemiological data cites that both rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have hereditary predilections.&#x000a0;&#x000a0;ertain families, as well as identical twins, promote the importance of genetic factors (60% association&#x000a0;in RA), but environmental factors certainly&#x000a0;play a role.</p>
        <p>In RA cases, HLA-DR4 and HLA-DR1 are thought to be very important genetic background.&#x000a0;This is particularly&#x000a0;true among smokers with a positive anti-cyclic&#x000a0;citrullinated&#x000a0;peptide (anti-CCP). HLA-B27 is the strongest genetic association of AS (first reported in 1973), but&#x000a0;HLA-DRB1 has also been linked to this disease.&#x000a0;HLA-B27 is not associated with RA.</p>
        <p>The genetic predisposition&#x000a0;and environmental factors will&#x000a0;start an&#x000a0;autoimmune reaction and&#x000a0;antibodies will attack the synovium, soft tissue, causing inflammation and gradual destruction in the organs.</p>
      </sec>
      <sec id="article-28518.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Symmetrical inflammation of various joints of the hands and feet (metacarpophalangeal, proximal interphalangeal, wrist, and metatarsophalangeal joints) are the most common initial manifestations of rheumatoid arthritis (RA). The morning stiffness feeling often lasts more than an hour. As the disease progress, erosion happens, leading to the characteristic deformation of the fingers and toes.<xref ref-type="bibr" rid="article-28518.r12">[12]</xref></p>
        <p>
<bold>Rheumatoid Spondylitis</bold>
</p>
        <p>Diagnostic criteria for RA include inflammatory arthritis involving three or more joints and lasting more than 6 weeks, positive rheumatoid factor (RF),&#x000a0;and/or anti-citrullinated peptide/protein antibody testing. Inflammatory markers such as&#x000a0;C-reactive protein (CRP) or the erythrocyte sedimentation rate (ESR) can be elevated, and symptoms cannot be attributed to other pathologies such as psoriatic arthritis, acute viral polyarthritis, polyarticular gout or calcium pyrophosphate deposition disease, and systemic lupus erythematosus.</p>
        <p>Patients with RA that develop cervical spondylitis can present with occipital headaches secondary to compression of the greater occipital branch of the C2 nerve, which occurs secondary to&#x000a0;degeneration of the C1-C2 joint.</p>
        <p>A classic grading system that has been utilized&#x000a0;to categorize severity of neurologic impairment with RA spondylitis is the Ranawat Classification System:</p>
        <list list-type="bullet">
          <list-item>
            <p>Grade I: Subjective paresthesias, pain</p>
          </list-item>
          <list-item>
            <p>Grade II: Subjective weakness, upper motor neuron findings</p>
          </list-item>
          <list-item>
            <p>Grade III: Objective weakness, upper motor neuron findings
<list list-type="bullet"><list-item><p>IIIA: Ambulatory</p></list-item><list-item><p>IIIB: Nonambulatory</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Careful consideration is given to IIIB patients as&#x000a0;the literature notes significant controversy with respect to additional benefits (at the cost of significantly&#x000a0;high morbidity rates postoperatively) in managing these patients with surgical intervention.&#x000a0;<xref ref-type="bibr" rid="article-28518.r13">[13]</xref></p>
        <p>
<bold>Ankylosing Spondylitis</bold>
</p>
        <p>Ankylosing spondylitis (AS)&#x000a0;is normally classified as an axial spondyloarthropathy and&#x000a0;mainly presented with chronic back pain and&#x000a0;bilateral, severe arthritis of the sacroiliac joints and lumbosacral spine. Back pain is severe and starts before age of 40. It is insidious in onset, improves with exercise but not with rest, and is worse&#x000a0;at night. AS can lead to disabling spinal fusion and hyperkyphosis. Peripheral arthritis only happens&#x000a0;in about a third of cases. If they happen,&#x000a0;changes are asymmetric and involve one large joint like the hip, knee, or shoulder. Erosion is rare.<xref ref-type="bibr" rid="article-28518.r11">[11]</xref></p>
        <p>Axial spondyloarthritis consists of AS and non-radiographic axial spondyloarthritis, which are characterized by symptoms of spinal inflammation and other features shared with spondyloarthritis&#x000a0;in general.<xref ref-type="bibr" rid="article-28518.r14">[14]</xref><xref ref-type="bibr" rid="article-28518.r15">[15]</xref><xref ref-type="bibr" rid="article-28518.r16">[16]</xref><xref ref-type="bibr" rid="article-28518.r17">[17]</xref></p>
      </sec>
      <sec id="article-28518.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ankylosing spondylitis (AS) happens at a younger age and involves the sacroiliac joints in an HLA-B27-positive male&#x000a0;patient. Rheumatoid arthritis (RA) cases usually&#x000a0;involve middle-aged females with symmetrical small&#x000a0;hand and wrist joint involvement. Tests for ESR, CRP, rheumatoid factor, anti-CCP antibody, HLAB27, HLA-DR2, and HLA-DR4 are all helpful in diagnosis. The first of these are nonspecific.<xref ref-type="bibr" rid="article-28518.r18">[18]</xref></p>
        <p>Plain x-rays show sacroiliitis in axial AS and most patients with non-axial AS. Magnetic resonance imaging (MRI) shows&#x000a0;bone edema and more subtle changes of inflammation.<xref ref-type="bibr" rid="article-28518.r19">[19]</xref></p>
        <p>AS and RF&#x000a0;can co-exist,&#x000a0;however, some studies have indicated that there is no erosion polyarthritis among AS patients who have a positive rheumatoid factor test.</p>
      </sec>
      <sec id="article-28518.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of both groups&#x000a0;somewhat&#x000a0;follows the same&#x000a0;algorithm,&#x000a0;although&#x000a0;individualized treatment is the goal. The level of disease activity,&#x000a0;the presence of&#x000a0;poor prognostic factors or concomitant illnesses, functional impairment, the patient's tolerance of medication, the risk of adverse effects, the expectations of treatment, and other psychosocial factors must&#x000a0;be considered.<xref ref-type="bibr" rid="article-28518.r20">[20]</xref></p>
        <p>NSAIDS and pain medication are usually the first choice and can be given for weeks to months. Exercise and physical therapy will benefit all and&#x000a0;prevent long-term joint stiffness, damage, and functional impairment. Traditional biologics such as methotrexate, Leflunomide&#x000a0;and sulfasalazine are effective in RA but not AS. Anti-tumor necrosis factor agents are effective in AS. Systemic glucocorticoids are best avoided especially in long-term.</p>
        <p>Surgical interventions are tailored to individual patients. Fusion of the atlantoaxial joint of the cervical spine is needed if there is significant neck or occipital pain or evidence of neurologic dysfunction due to C1-C2 subluxation, as occurs in patients with rheumatoid arthritis but not AS. Joint replacement might be needed.</p>
      </sec>
      <sec id="article-28518.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Axial AS&#x000a0;patients may also have peripheral arthritis, enthesitis, and dactylitis, which can lead to a wrong diagnosis of RA.</p>
      </sec>
      <sec id="article-28518.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Both diseases are chronic and can be managed over time for years before fatal complications happen. Many of the symptoms can be effectively controlled via medical and surgical means. Risk of cardiovascular diseases is increased in both entities, possibly secondary to the generalized inflammation that is present. Therefore, many of these patients suffer or&#x000a0;pass away prematurely from cardiac causes, not necessarily RA and AS.<xref ref-type="bibr" rid="article-28518.r21">[21]</xref><xref ref-type="bibr" rid="article-28518.r22">[22]</xref><xref ref-type="bibr" rid="article-28518.r23">[23]</xref></p>
      </sec>
      <sec id="article-28518.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consult rheumatology, orthopedic surgery, and rehabilitative services.</p>
      </sec>
      <sec id="article-28518.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Rheumatoid spondylitis in elective surgery:</p>
        <list list-type="bullet">
          <list-item>
            <p>Any patient with RA should have flexion/extension films prior to having elective surgery</p>
          </list-item>
          <list-item>
            <p>RA spondylitis most commonly affects the occipitoatlantoaxial&#x000a0;joint</p>
          </list-item>
          <list-item>
            <p>Ranawat grade IIIB patients (nonambulatory) have high associated morbidity when it comes to performing surgical intervention -- thus the literature is very controversial with respect to the use of surgery in this unique subset of RA spondylitis patients</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28518.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Rheumatological diseases are chronic entities, and close work of an interprofessional team is needed for their management. Rheumatologists, orthopedic surgeons, primary care physicians, pharmacists, and physical therapists are all taking part in the lifelong challenge of controlling patient symptoms and increasing the quality of care and quality of life.</p>
      </sec>
      <sec id="article-28518.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28518&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28518">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/arthritis/rheumatoid-arthritis-and-ankylosing-spondylitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28518">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28518/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28518">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28518.s15">
        <title>References</title>
        <ref id="article-28518.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atkinson</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Brophy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Siebert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gravenor</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2010</year>
            <month>Sep</month>
            <day>01</day>
            <volume>11</volume>
            <fpage>197</fpage>
            <pub-id pub-id-type="pmid">20809952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macfarlane</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>RIR</given-names>
              </name>
              <name>
                <surname>Pathan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Siebert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gaffney</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Choy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Packham</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Haywood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sengupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Atzeni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>57</volume>
            <issue>11</issue>
            <fpage>1982</fpage>
            <page-range>1982-1990</page-range>
            <pub-id pub-id-type="pmid">30053166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barczy&#x00144;ska</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>W&#x00119;gierska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x0017b;uchowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zalewska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Waszczak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jeka</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Coexistence of rheumatoid arthritis and ankylosing spondylitis.</article-title>
            <source>Reumatologia</source>
            <year>2015</year>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>279</fpage>
            <page-range>279-85</page-range>
            <pub-id pub-id-type="pmid">27407260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aradoini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Talbi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azzouzi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abourazzak</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Khibri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Berrady</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bono</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Harzy</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Ankylosing spondylitis associated with Still's disease: should it be considered a pathophysiologic link or a simple association?].</article-title>
            <source>Pan Afr Med J</source>
            <year>2017</year>
            <volume>28</volume>
            <fpage>132</fpage>
            <pub-id pub-id-type="pmid">29515750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortega Castro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Font Ugalde</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Castro Villegas</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Calvo Guti&#x000e9;rrez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz Gomariz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zarco Montejo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Almod&#x000f3;var</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mulero Mendoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torre-Alonso</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gratac&#x000f3;s Masmitj&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Juanola Roura</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ariza Ariza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez Dapica</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Linares Ferrando</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Brito Brito</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cuende Quintana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez Galeano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moreno Ramos</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Gim&#x000e9;nez &#x000da;beda</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez Lozano</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez Prada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Queiro Silva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moreno Ruzafa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>J&#x000fa;dez Navarro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>M&#x000e1;s</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Medrano Le Quement</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ornilla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Montilla Morales</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pujol Busquets</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clavaguera Poch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Espartero</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Carmona Ortell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Collantes Est&#x000e9;vez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER.</article-title>
            <source>Reumatol Clin</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-5</page-range>
            <pub-id pub-id-type="pmid">23474378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kisacik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tufan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalyoncu</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Karadag</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akdogan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kiraz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ertenli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Calguneri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis.</article-title>
            <source>Joint Bone Spine</source>
            <year>2008</year>
            <month>May</month>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-4</page-range>
            <pub-id pub-id-type="pmid">18403245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Layh-Schmitt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Navid</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lazowick</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Montagna</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gadina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Colbert</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.</article-title>
            <source>Clin Rheumatol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-154</page-range>
            <pub-id pub-id-type="pmid">27864696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matei</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moise</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Su&#x00163;eanu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[An association between ankylosing spondylitis and rheumatoid polyarthritis; comments on 3 cases].</article-title>
            <source>Med Interna</source>
            <year>1992</year>
            <volume>44</volume>
            <issue>2-4</issue>
            <fpage>61</fpage>
            <page-range>61-5</page-range>
            <pub-id pub-id-type="pmid">1345061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Update on ankylosing spondylitis: current concepts in pathogenesis.</article-title>
            <source>Curr Allergy Asthma Rep</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>489</fpage>
            <pub-id pub-id-type="pmid">25447326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Donnally III</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Munakomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Basilar Invagination</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">28846299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taurog</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Chhabra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colbert</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Ankylosing Spondylitis and Axial Spondyloarthritis.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Sep</month>
            <day>29</day>
            <volume>375</volume>
            <issue>13</issue>
            <fpage>1303</fpage>
            <pub-id pub-id-type="pmid">27682050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caporali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zavaglia</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Real-world experience with tofacitinib for the treatment of rheumatoid arthritis.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2019</year>
            <season>May-Jun</season>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>485</fpage>
            <page-range>485-495</page-range>
            <pub-id pub-id-type="pmid">30183607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nannapaneni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Behari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>NV</given-names>
              </name>
            </person-group>
            <article-title>Surgical outcome in rheumatoid Ranawat Class IIIb myelopathy.</article-title>
            <source>Neurosurgery</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>706</fpage>
            <page-range>706-15; discussion 706-15</page-range>
            <pub-id pub-id-type="pmid">15792509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hodler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Rufibach</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Kissling</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Pfirrmann</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Maksymowych</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain.</article-title>
            <source>Arthritis Rheum</source>
            <year>2009</year>
            <month>Jul</month>
            <day>15</day>
            <volume>61</volume>
            <issue>7</issue>
            <fpage>900</fpage>
            <page-range>900-8</page-range>
            <pub-id pub-id-type="pmid">19565558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Buchanan</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Sacroiliitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">28846269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tafti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Sacroiliac Joint Injection</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">30020617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Brutzkus</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Shahrokhi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Naproxen</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">30247840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0015e;ahin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yeti&#x0015f;gin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x0015e;ahin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Durmaz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cengiz</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Can Mean Platelet Volume Be a Surrogate Marker of Inflammation in Rheumatic Diseases?</article-title>
            <source>West Indian Med J</source>
            <year>2015</year>
            <month>May</month>
            <day>06</day>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>165</fpage>
            <page-range>165-169</page-range>
            <pub-id pub-id-type="pmid">26645595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Jun</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>"MR corner sign": value for predicting presence of ankylosing spondylitis.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>191</volume>
            <issue>1</issue>
            <fpage>124</fpage>
            <page-range>124-8</page-range>
            <pub-id pub-id-type="pmid">18562734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ward</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Deodhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Akl</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gensler</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Borenstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hiratzka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Majithia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Haroon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Maksymowych</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Joyce</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Colbert</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Figgie</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Hallegua</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Prete</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Stebulis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Reveille</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.</article-title>
            <source>Arthritis Rheumatol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>282</fpage>
            <page-range>282-98</page-range>
            <pub-id pub-id-type="pmid">26401991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Essers</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stolwijk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boonen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Bruin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bazelier</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>van Tubergen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>203</fpage>
            <page-range>203-9</page-range>
            <pub-id pub-id-type="pmid">25362044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schieir</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tosevski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Glazier</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hogg-Johnson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Badley</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>8</issue>
            <fpage>1396</fpage>
            <page-range>1396-1404</page-range>
            <pub-id pub-id-type="pmid">28219882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28518.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sinnathurai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buchbinder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lassere</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>March</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2018</year>
            <month>Aug</month>
            <day>07</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>171</fpage>
            <pub-id pub-id-type="pmid">30086795</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
